Trademark Overview
On Monday, June 23, 2025, a trademark application was filed for AXIMRIS XR with the United States Patent and Trademark Office. The USPTO has given the AXIMRIS XR trademark a serial number of 99247604. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 23, 2025. This trademark is owned by Zurich Pharma INC. The AXIMRIS XR trademark is filed in the Pharmaceutical Products category with the following description:
Drug delivery systems comprising controlled timed-release and/or targeted-release pharmaceutical formulations, provided as integral components of pharmaceutical preparations; pharmaceutical preparations incorporating such drug delivery systems in the form of oral solid dosage units, namely tablets and capsules; all for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric and gastrointestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis, and rhinitis.
